Does FDG PET-Assisted Management of Patients With Left Ventricular Dysfunction Improve Quality of Life? A Substudy of the PARR-2 Trial
Tushar Shukla(St. Michael's Hospital), Rob Beanlands(University of Ottawa), Karen Y. Gulenchyn(McMaster University), George A. Wells(University of Ottawa), Graham Nichol(University of Washington), Benjamin J.W. Chow(Tufts Medical Center), Jean N. DaSilva(Centre Hospitalier de l’Université de Montréal), François Bénard(BC Cancer Agency), Robert A. deKemp(University of Ottawa), Majed Haddad(Mount Sinai Hospital), Lloyd Duchesne(St. Michael's Hospital), Linda Garrard(University of Ottawa), Michael R. Freeman(Cedars-Sinai Medical Center), Terrence D. Ruddy(University of Ottawa), Dennis P. Humen(St. Michael's Hospital), Li Chen(ShanghaiTech University), Ross A. Davies(St. Michael's Hospital), Ann Guo(University of Ottawa), Normand Racine(Montreal Heart Institute)
Cited by 16
Related Papers
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
|New England Journal of Medicine|1999|5.2k
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
|Circulation|2010|4.8k
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure
|New England Journal of Medicine|2010|1.8k
The Canadian CT Head Rule for patients with minor head injury
|The Lancet|2001|1.5k